Login to Your Account

Bench Press: BioWorld Looks at Translational Medicine

Monday, July 29, 2013
Scientists from the Aaron Diamond AIDS Research Center have described bispecific antibodies that were able to neutralize more than 100 HIV strains at very low concentrations, suggesting that such antibodies might be useful for either treatment of HIV-infected individuals or pre-exposure prophylaxis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription